Previous Article | Next Article ![]()
Journal of Clinical Microbiology, May 1997, 1151-1156, Vol 35, No. 5
A Dalsgaard, MN Skov, O Serichantalergs, P Echeverria, R Meza and DN Taylor
Following the emergence of cholera in Lima, Peru, in 1991, isolates of
Vibrio cholerae O1 biotype El Tor recovered from patients in various parts
of Lima were selected and characterized. Ribotyping and pulsed- field gel
electrophoresis (PFGE) revealed four BglI ribotypes and eight NotI PFGE
types among 50 V. cholerae O1 strains recovered from patients with cholera
in Lima from 1991 to 1995, with certain genotypes appearing to cluster
geographically. While differences in ribotype and PFGE type patterns
suggest that genetic changes are occurring in the strain responsible for
the Latin American cholera epidemic, more frequently than previously
reported, 40 (80%) O1 strains showed an identical ribotype pattern and 41
(82%) strains showed closely related PFGE types, types 1, 2, or 3, that
differed by less than three restriction fragments. All strains were
susceptible to nine antibacterial agents studied. In 1991, more than 95% of
the clinical V. cholerae O1 strains were serotype Inaba, whereas from 1992,
serotype Ogawa began to predominate, with more than 90% of the isolates
being of the Ogawa serotype in 1995. The small differences in genotypes of
V. cholerae O1 is remarkable because cholera is highly seasonal in coastal
areas of Peru and support the hypothesis that the epidemic strain reemerges
from an environmental source. However, the relative high rate of genetic
changes within V. cholerae O1 as shown by ribotyping and PFGE should be
taken into consideration when typing patterns of V. cholerae O1 associated
with cholera in Latin America are evaluated.
Copyright © 1997 by the American Society for Microbiology. All rights reserved.
Molecular evolution of Vibrio cholerae O1 strains isolated in Lima, Peru, from 1991 to 1995
Department of Veterinary Microbiology, Royal Veterinary and Agricultural University, Frederiksberg, Denmark. Anders.Dalsgaard@vetmi.kvl.dk
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|